Carvedilol
Product Images NDC 53808-0603

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 53808-0603). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carvedilol Label, 12.5 mg (Carvedilol 12.5mg(glenmark))

Label for Carvedilol 12.5 mg tablets, prescription only, with a quantity of 30 tablets per package. The label includes lot numbers, expiration date, packaging by the State of Florida DOH Central Pharmacy in Tallahassee, FL, and a barcode with UPC.*

FDA Label Image

Carvedilol Label, 3.125 mg (Carvedilol 3.125mg(glenmark))

Carvedilol 3.125 mg tablet label displaying quantity of 30 tablets, manufactured or packaged by DOH Central Pharmacy, Tallahassee, FL 32304. Label includes lot numbers, expiration date formatted as MM/DD/YYYY, and a barcode with UPC number.*

FDA Label Image

Carvedilol Label, 6.25 mg (Carvedilol 6.25mg(glenmark))

Carvedilol 6.25 mg tablets label showing a quantity of 30 tablets. The label includes prescription-only status, lot number T267A09A, and states the product is packaged by DOH Central Pharmacy, Tallahassee, FL. A barcode and UPC number 368452163016 are also visible.*

FDA Label Image

Carvedilol Label, 25 mg (Carvedilol25mg(glenmark))

Label for Carvedilol 25 mg tablets, quantity of 30, supplied by State of Florida DOH Central Pharmacy, Tallahassee, FL. The label includes prescription-only indication, lot numbers, expiration date, and a barcode with UPC 358462165010.*

FDA Label Image

Structural Formula For Carvedilol (C4a21f67 7812 4634 Beba F8e85c63c5f2 01)

Chemical structure of carvedilol, depicted as a detailed molecular diagram showing its atomic and bond arrangement including aromatic rings and functional groups.*

FDA Label Image

Figure 1 (C4a21f67 7812 4634 Beba F8e85c63c5f2 02)

A line graph comparing percentage mortality over time (months) between Carvedilol and placebo groups. The x-axis represents months up to 21, and the y-axis shows percentage mortality up to 30%. The graph indicates lower mortality for Carvedilol compared to placebo with a p-value of 0.0014.*

FDA Label Image

Figure 2 (C4a21f67 7812 4634 Beba F8e85c63c5f2 03)

A forest plot illustrating hazard ratios with confidence intervals for various patient subgroups, including gender, age groups, race, diabetic status, ischemic condition, heart rate, systolic blood pressure, and spironolactone use, compared against a reference line at 1.0.*

FDA Label Image

Figure 3 (C4a21f67 7812 4634 Beba F8e85c63c5f2 04)

A line graph depicting percentage mortality over a 24-month period comparing Carvedilol treatment to placebo. The graph shows mortality increasing over time for both groups, with the placebo group having higher mortality. A P-value of 0.0014 is indicated, suggesting statistical significance.*

FDA Label Image

Figure 4 (C4a21f67 7812 4634 Beba F8e85c63c5f2 05)

A forest plot chart depicting hazard ratios on the horizontal axis for various patient subgroups including age, gender, medical history (e.g., prior congestive heart failure, myocardial infarction treatments), and clinical conditions like hypertension and diabetes. Each subgroup is represented by a dot with horizontal confidence intervals, comparing hazard ratios below or above 1.0 for different patient characteristics.*

FDA Label Image

Glenmark Logo (C4a21f67 7812 4634 Beba F8e85c63c5f2 06)

FDA Label Image

Glenmark Logo (C4a21f67 7812 4634 Beba F8e85c63c5f2 07)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.